Mind Medicine Australia FREE Webinar – Psychedelics and How They Work in the Brain · Mind Medicine Australia
Mind Medicine Australia logo Menu

Mind Medicine Australia FREE Webinar – Psychedelics and How They Work in the Brain

With Prof Robin Carhart-Harris (USA)

Date: Wed 13 November 2024 @ 12:00pm
Location: Webinar (online)

Don’t miss out – Get your tickets early!

Join this FREE WEBINAR presented by Professor Robin Carhart-Harris (USA).

Professor Robin Carhart-Harris leads pioneering psychedelic research, including clinical trials for depression, and established the Centre for Psychedelic Research at Imperial College, London.

TOPIC: Psychedelics and How They Work in the Brain

 

This talk will take a multi-level view of the brain action of classic psychedelic drugs, i.e., drugs that share the property of activating the serotonin 2A receptor. Beginning at the receptor level, it moves through a developmental and evolutionary understanding of serotonergic functioning and brain plasticity, placing emphasis on the context dependency of responses to classic psychedelic compounds.

It reviews the dynamic, whole-brain action of psychedelics and how this relates to knowledge of the development and evolution of global brain function and anatomy. It couches our understanding of the therapeutic action of psychedelic therapy within a predictive coding framework and reviews recent trial and imaging results from a double-blind randomized controlled trial of psilocybin therapy vs escitalopram for depression.

 

EVENT DETAILS

DATE: 13th November 2024
TIME: 11:55am (AEDT) for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online – a link will be emailed to you with the viewing details

The Presenters

Prof Robin Carhart-Harris (USA)

BSc, Ph.D

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, he has run and overseen brain imaging studies involving LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression, and a current study comparing psilocybin with escitalopram for major depressive disorder. In 2019, he set-up the Centre for Psychedelic Research at Imperial and he also an honorary position with the University of Oxford. Two of his most influential works include the ‘Entropic Brain Hypothesis’ and ‘REBUS and the anarchic brain’.

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×